RedixFi
RedixFi

AGARWALEYE · Concall Summary

DR AGARWALS HEALTH CARE L

Concall2026-08-07
Tone: Positive

During the Q1 FY27 earnings conference call, management reported record-breaking results, launching 16 new surgical facilities and achieving revenue from operations of INR614 crores, an 8.8% sequential growth. Total income for the quarter reached INR620 crores, up 24% year-on-year, with a robust Ind AS EBITDA of INR177 crores, reflecting a 25.2% year-on-year increase. The company expanded its network by commissioning 18 new greenfield facilities, serving over 8.8 lakh patients and performing over 90,000 surgeries. Management highlighted strong growth in high-end surgeries, including a 33.4% increase in robotic cataract surgeries. The Southern region remained the largest market, contributing 63% of revenues, while the North region showed significant growth of 50.5% year-on-year. Management set a goal to add 60 new facilities in FY27, with 18 already launched in Q1. The call concluded with a focus on maintaining operational efficiency and growth momentum.

Management emphasized strong growth and operational achievements during the quarter.

View source filing →

Earlier concalls

  • 2026-08-04The investor presentation from Dr. Agarwal's Health Care Limited detailed the company's unaudited financial results for
  • 2026-05-27During the earnings conference call held on May 21, 2026, management reported that Dr. Agarwal's Healthcare Limited achi
  • 2026-05-21The investor presentation from Dr. Agarwal's Health Care Limited detailed the company's audited financial results for th

See AGARWALEYE's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.

Sign up free

Back to AGARWALEYE snapshot